GB0901900D0 - Dual calpain-ros inhibitors - Google Patents

Dual calpain-ros inhibitors

Info

Publication number
GB0901900D0
GB0901900D0 GBGB0901900.1A GB0901900A GB0901900D0 GB 0901900 D0 GB0901900 D0 GB 0901900D0 GB 0901900 A GB0901900 A GB 0901900A GB 0901900 D0 GB0901900 D0 GB 0901900D0
Authority
GB
United Kingdom
Prior art keywords
calpain
dual
ros inhibitors
ros
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0901900.1A
Other versions
GB2467562A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit Therapeutics Ltd
Original Assignee
Summit Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Corp PLC filed Critical Summit Corp PLC
Priority to GB0901900A priority Critical patent/GB2467562A/en
Publication of GB0901900D0 publication Critical patent/GB0901900D0/en
Publication of GB2467562A publication Critical patent/GB2467562A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
GB0901900A 2009-02-06 2009-02-06 Dual calpain-ROS inhibitors Withdrawn GB2467562A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0901900A GB2467562A (en) 2009-02-06 2009-02-06 Dual calpain-ROS inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0901900A GB2467562A (en) 2009-02-06 2009-02-06 Dual calpain-ROS inhibitors

Publications (2)

Publication Number Publication Date
GB0901900D0 true GB0901900D0 (en) 2009-03-11
GB2467562A GB2467562A (en) 2010-08-11

Family

ID=40469637

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0901900A Withdrawn GB2467562A (en) 2009-02-06 2009-02-06 Dual calpain-ROS inhibitors

Country Status (1)

Country Link
GB (1) GB2467562A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3191112T3 (en) * 2014-09-08 2019-06-17 Landsteiner Genmed S L Dipeptidylketoamide compounds and their use for the treatment and / or prevention of fat accumulation
EP3564211A1 (en) * 2018-05-03 2019-11-06 Landsteiner Genmed, S.L. Dipeptidyl ketoamide meta-methoxyphenyl derivatives and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2138124A1 (en) * 1992-06-24 1994-01-06 David D. Eveleth, Jr. Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
US5514694A (en) * 1992-09-21 1996-05-07 Georgia Tech Research Corp Peptidyl ketoamides
US6686335B1 (en) * 1998-09-22 2004-02-03 Cephalon, Inc. Hydroxamate-containing cysteine and serine protease inhibitors
FR2816509B1 (en) * 2000-11-15 2004-02-06 Sod Conseils Rech Applic ASSOCIATION OF CALPAIN INHIBITORS AND OXYGEN REACTIVE TRAPS
WO2009099416A1 (en) * 2008-02-06 2009-08-13 Georgia Tech Research Corporation Heterocyclic peptide ketoamides

Also Published As

Publication number Publication date
GB2467562A (en) 2010-08-11

Similar Documents

Publication Publication Date Title
DK3023438T3 (en) Anti-gitr-antistoffer
DK2457337T3 (en) Specialtilpasset impuls-burst
HK1179477A1 (en) Kinase inhibitors
ZA201203842B (en) Kinase inhibitors
EP2462514A4 (en) Greenbooks
EP2558099A4 (en) Kinase inhibitors
EP2515891A4 (en) 3-keto-n-propargyl-1-aminoindan
ZA201108858B (en) Iap inhibitors
EP2519921A4 (en) Call-tracking
DK2464943T3 (en) Systemintegration
GB0901898D0 (en) Dual calpain-ros inhibitors
EP2421882A4 (en) Angiogenesis inhibitors
ZA201108709B (en) Iap inhibitors
EP2496230A4 (en) Ire-1 alpha inhibitors
EP2480076A4 (en) Imidothiazole kinase inhibitors
ZA201102837B (en) Phosphodiestarase inhibitors
GB0901900D0 (en) Dual calpain-ros inhibitors
ZA201200811B (en) Cathepsin c inhibitors
GB0914726D0 (en) Kinase inhibitors
EP2510125A4 (en) Hyperprimers
GB0903650D0 (en) Glyoalase inhibitors
GB0902661D0 (en) Inhibitors
GB0915927D0 (en) Novel inhibitors
GB0906919D0 (en) Inhibitor complex structure
AU4925P (en) Bonscawi Scaevola aemula

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)